Meet Robert Daly: Thoracic Medical Oncologist at MSK

Dr. Robert Daly treats mesothelioma and lung cancer, including non-small cell and small cell, at MSK, using telemedicine when needed to deliver personalized care.
Video Details
 Memorial Sloan Kettering medical oncologist Robert Daly

Robert Daly, MD, MBA

Thoracic Medical Oncologist

Areas of Expertise

Conditions I Treat

  • Lung cancer
  • Non-small cell lung cancer (NSCLC)
  • Small cell lung cancer (SCLC)

My Specialties

  • Clinical trials
  • Integrative medicine
  • Telemedicine
View more expertise
Dr. Daly's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a medical oncologist who specializes in caring for people with lung cancer. I am also a health services researcher who is interested in innovative cancer care systems that provide high quality, affordable, and sustainable care.

How MSK is Making Patient Care More Accessible
Watch how leveraging technology can improve patient-centered cancer care at Memorial Sloan Kettering.
Learn more

My graduate education at Harvard Medical School and Harvard Business School, where my work focused on improving care delivery in a resource-poor setting, gave me an appreciation for improving complex healthcare systems. I also performed research at Massachusetts General Hospital that focused on ways for leaders to make hospitals safer and graduated with honors for this work. 

My research has evolved to study aspects of cancer care delivery including disparities in cancer care, the overuse of aggressive treatments at the end of life, and interventions to improve the quality of care delivery. I was selected as one of the American Society of Clinical Oncology’s inaugural health policy fellows; in this role I am working to identify and prioritize policy areas for intervention to improve the value of cancer care.

One of my patients’ top concerns is balancing treatment with quality of life. My goal for them and their caregivers is to feel like their concerns and personal goals have been heard, recognized, and incorporated into their personalized care plan.

What I Do at MSK

I'm a thoracic medical oncologist, which is a cancer doctor who specializes in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.

  • Associate Attending Physician
Areas of Expertise

Conditions I Treat

  • Lung cancer
  • Non-small cell lung cancer (NSCLC)
  • Small cell lung cancer (SCLC)
  • Pleural mesothelioma
  • Peritoneal mesothelioma
  • Carcinoid tumors

My Specialties

  • Clinical trials
  • Integrative medicine
  • Telemedicine
Education & Honors

Education

  • MD, Harvard Medical School
  • MBA, Harvard Business School

Residencies

  • Internal Medicine, New York Presbyterian/Weill Cornell Medical Center

Fellowships

  • Hematology/Oncology, University of Chicago Medicine

Board Certifications

  • Internal Medicine
  • Medical Oncology

Awards and Honors

  • Advocacy Champion, American Society of Clinical Oncology (ASCO) (2022-2023)
  • Judges’ Choice and Patients’ Choice Award, Quality Improvement Fair (2020)
  • Innovator Award, Healthcare Innovation (2020)
  • Dean's Award, Harvard Medical School, Harvard Business School
  • ASCO Health Policy Fellowship (2016)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9163— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Office Phone
Location
New York, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all MATCHES Members doctors

See all Members doctors

See all Thoracic Oncology Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

  1. Mao JJ, Bryl K, Gillespie EF, Green A, Hung TKW, Baser R, Panageas K, Postow MA, Daly B. Randomized clinical trial of a digital integrative medicine intervention among patients undergoing active cancer treatment. NPJ Digit Med. 2025 Jan 14;8(1):29. doi: 10.1038/s41746-024-01387-z. PubMed PMID: 39809874; PubMed Central PMCID: PMC11733120.
  2. Liu SY, Doshi SD, Ebstein AM, Holland J, Sapir A, Leung M, Huang J, Fahy R, Salvaggio R, Begue A, Kuperman G, Polubriaginof FGC, Stetson PD, Mao JJ, Panageas K, Li B, Daly B. Waiting to Exhale: The Feasibility and Appropriateness of Home Blood Oxygen Monitoring in Oncology Patients Post-Hospital Discharge. JCO Clin Cancer Inform. 2024 Nov;8:e2400182. doi: 10.1200/CCI-24-00182. Epub 2024 Nov 20. PubMed PMID: 39565969.
  3. Bange EM, Bernal C, Gaffney KB, Ackerman J, Kwong D, Thomas J, Daly B. The feasibility and acceptability of home phlebotomy for patients with cancer. JNCI Cancer Spectr. 2024 Nov 1;8(6). doi: 10.1093/jncics/pkae104. PubMed PMID: 39412474; PubMed Central PMCID: PMC11547947.
  4. Daly B, Cracchiolo J, Holland J, Ebstein AM, Flynn J, Duck E, Moy M, Walters CB, Giacomazzo L, Huang J, Fahy R, Bernal C, Ackerman J, Salvaggio R, Begue A, Raj N, Kuperman G, Mao JJ, Panageas K. Digitally Enabled Transitional Care Management in Oncology. JCO Oncol Pract. 2024 May;20(5):657-665. doi: 10.1200/OP.23.00565. Epub 2024 Feb 21. PubMed PMID: 38382002.

 

Publications on PubMed

Visit PubMed for a full listing of Dr. Daly’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.

MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.

Robert Daly discloses the following relationships and financial interests:

  • I-Mab Biopharma
    Professional Services and Activities
  • IMspire
    Equity
  • Main Street Health Medical Partners, P.C.
    Professional Services and Activities (Uncompensated)
  • Varian Medical Systems
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures

Related topics: